Cargando…
Leveraging the power of pooled data for cancer outcomes research
BACKGROUND: Clinical trials continue to be the gold standard for determining the efficacy of novel cancer treatments, but they may also expose participants to the potential risks of unpredictable or severe toxicities. The development of validated tools that better inform patients of the benefits and...
Autores principales: | Hugh-Yeun, Kiara, Cheung, Winson Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971686/ https://www.ncbi.nlm.nih.gov/pubmed/27484162 http://dx.doi.org/10.1186/s40880-016-0132-0 |
Ejemplares similares
-
Peripheral and systemic antigens elicit an expandable pool of resident memory CD8(+) T cells in the bone marrow
por: Pascutti, Maria Fernanda, et al.
Publicado: (2019) -
An effective platform for cancer immunotherapy: pooled knockin targeting for genome engineering
por: Jin, Ke, et al.
Publicado: (2020) -
The power of unbiased phenotypic screens – cellulose as a first receptor for the Schitoviridae phage S6 of Erwinia amylovora
por: Römling, Ute
Publicado: (2022) -
Genomic data sharing for translational research and diagnostics
por: Robinson, Peter N
Publicado: (2014) -
Model answers: Rational application of murine models in arthritis research
por: Benson, Robert A., et al.
Publicado: (2017)